DE60135907D1 - Wirkstoffverabreichungssysteme mit verzögerter freisetzung, verwendung und verfahren zur herstellung derselben - Google Patents
Wirkstoffverabreichungssysteme mit verzögerter freisetzung, verwendung und verfahren zur herstellung derselbenInfo
- Publication number
- DE60135907D1 DE60135907D1 DE60135907T DE60135907T DE60135907D1 DE 60135907 D1 DE60135907 D1 DE 60135907D1 DE 60135907 T DE60135907 T DE 60135907T DE 60135907 T DE60135907 T DE 60135907T DE 60135907 D1 DE60135907 D1 DE 60135907D1
- Authority
- DE
- Germany
- Prior art keywords
- aggravated
- manufacturing
- same
- delayed release
- effective agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
- A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T29/00—Metal working
- Y10T29/49—Method of mechanical manufacture
- Y10T29/49826—Assembling or joining
- Y10T29/49888—Subsequently coating
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/558,207 US6375972B1 (en) | 2000-04-26 | 2000-04-26 | Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
PCT/US2001/012700 WO2001080825A2 (en) | 2000-04-26 | 2001-04-19 | Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60135907D1 true DE60135907D1 (de) | 2008-11-06 |
Family
ID=24228594
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60135907T Expired - Lifetime DE60135907D1 (de) | 2000-04-26 | 2001-04-19 | Wirkstoffverabreichungssysteme mit verzögerter freisetzung, verwendung und verfahren zur herstellung derselben |
Country Status (24)
Country | Link |
---|---|
US (7) | US6375972B1 (de) |
EP (2) | EP1982701A3 (de) |
JP (1) | JP4705304B2 (de) |
KR (1) | KR100854541B1 (de) |
CN (4) | CN1438873A (de) |
AR (1) | AR028372A1 (de) |
AT (1) | ATE409023T1 (de) |
AU (4) | AU2001253675B2 (de) |
BR (1) | BR0110243A (de) |
CA (1) | CA2406277C (de) |
CY (1) | CY1108665T1 (de) |
DE (1) | DE60135907D1 (de) |
DK (1) | DK1276462T3 (de) |
EA (1) | EA004980B1 (de) |
ES (1) | ES2315282T3 (de) |
HK (1) | HK1053263B (de) |
IL (2) | IL152294A0 (de) |
MX (1) | MXPA02010442A (de) |
NZ (2) | NZ531721A (de) |
PT (1) | PT1276462E (de) |
SI (1) | SI1276462T1 (de) |
TW (1) | TWI290054B (de) |
WO (1) | WO2001080825A2 (de) |
ZA (1) | ZA200208415B (de) |
Families Citing this family (280)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2358296A1 (en) * | 1999-01-05 | 2000-07-13 | Anthony P. Adamis | Targeted transscleral controlled release drug delivery to the retina and choroid |
US20040121014A1 (en) * | 1999-03-22 | 2004-06-24 | Control Delivery Systems, Inc. | Method for treating and/or preventing retinal diseases with sustained release corticosteroids |
US6217895B1 (en) | 1999-03-22 | 2001-04-17 | Control Delivery Systems | Method for treating and/or preventing retinal diseases with sustained release corticosteroids |
US8556967B2 (en) | 1999-04-09 | 2013-10-15 | Faezeh Mona Sarfarazi | Interior bag for a capsular bag and injector |
US7943162B2 (en) * | 1999-10-21 | 2011-05-17 | Alcon, Inc. | Drug delivery device |
US6416777B1 (en) * | 1999-10-21 | 2002-07-09 | Alcon Universal Ltd. | Ophthalmic drug delivery device |
US20040175410A1 (en) * | 2000-04-26 | 2004-09-09 | Control Delivery Systems, Inc. | Sustained release device and method for ocular delivery of carbonic anhydrase inhibitors |
US20040208910A1 (en) * | 2000-04-26 | 2004-10-21 | Control Delivery Systems, Inc. | Sustained release device and method for ocular delivery of adrenergic agents |
US6375972B1 (en) | 2000-04-26 | 2002-04-23 | Control Delivery Systems, Inc. | Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
DK1313415T3 (da) * | 2000-08-30 | 2008-10-13 | Univ Johns Hopkins | Indretninger til intraokulær lægemiddeladministration |
JP2004517674A (ja) * | 2000-12-29 | 2004-06-17 | ボシュ・アンド・ロム・インコーポレイテッド | 徐放薬物送達装置 |
WO2002053129A1 (en) * | 2001-01-03 | 2002-07-11 | Bausch & Lomb Incorporated | Sustained release drug delivery devices with prefabricated permeable plugs |
WO2002053128A2 (en) * | 2001-01-03 | 2002-07-11 | Bausch & Lomb Incorporated | Sustained release drug delivery devices with multiple agents |
US20020148138A1 (en) * | 2001-04-06 | 2002-10-17 | Egan Brian A. | Smart tread boot covers |
US7431710B2 (en) | 2002-04-08 | 2008-10-07 | Glaukos Corporation | Ocular implants with anchors and methods thereof |
WO2002087586A1 (en) * | 2001-04-26 | 2002-11-07 | Control Delivery Systems, Inc. | Sustained release drug delivery system containing codrugs |
US20040022853A1 (en) * | 2001-04-26 | 2004-02-05 | Control Delivery Systems, Inc. | Polymer-based, sustained release drug delivery system |
EP1387671A1 (de) * | 2001-05-03 | 2004-02-11 | MASSACHUSETTS EYE & EAR INFIRMARY | Implantierbare arzneistoffverabreichungsvorrichtung und verwendung derselben |
CA2450771C (en) | 2001-06-12 | 2010-09-07 | Johns Hopkins University School Of Medicine | Reservoir device for intraocular drug delivery |
AU2002324447B2 (en) * | 2001-06-22 | 2006-06-29 | Durect Corporation | Zero-order prolonged release coaxial implants |
JP4426286B2 (ja) * | 2001-07-10 | 2010-03-03 | テバ ファーマシューティカル インダストリーズ リミティド | 0次、0次−二相性、上昇型又は下降型薬物放出のための薬物送達システム |
CN100349562C (zh) * | 2001-07-23 | 2007-11-21 | 爱尔康公司 | 眼部药物输送装置 |
AU2002319596B2 (en) | 2001-07-23 | 2006-04-27 | Alcon, Inc. | Ophthalmic drug delivery device |
IN2014DN10834A (de) * | 2001-09-17 | 2015-09-04 | Psivida Inc | |
US20060034929A1 (en) * | 2001-12-27 | 2006-02-16 | Brubaker Michael J | Sustained release drug delivery devices with prefabricated permeable plugs |
WO2003071986A2 (en) * | 2002-02-22 | 2003-09-04 | Control Delivery Systems, Inc. | Method for treating otic disorders |
KR101127502B1 (ko) * | 2002-03-11 | 2012-03-23 | 알콘, 인코퍼레이티드 | 이식 가능한 약물 전달 시스템 |
US20050222061A1 (en) * | 2002-04-18 | 2005-10-06 | Schulte Ralf W | Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye |
AU2003217531A1 (en) * | 2002-05-02 | 2003-11-17 | Massachusetts Eye And Ear Infirmary | Ocular drug delivery systems and use thereof |
MXPA04011004A (es) * | 2002-05-07 | 2005-01-25 | Control Delivery Sys Inc | Procesos para formar un dispositivo de administracion de farmaco. |
US8871241B2 (en) * | 2002-05-07 | 2014-10-28 | Psivida Us, Inc. | Injectable sustained release delivery devices |
WO2003096991A2 (en) | 2002-05-17 | 2003-11-27 | Othera Pharmaceuticals, Inc. | Amelioration of the development of cataracts and other opthalmic diseases |
US6976584B2 (en) * | 2002-06-26 | 2005-12-20 | Bausch & Lomb Incorporated | Package for surgical implant |
CN100435880C (zh) * | 2003-02-28 | 2008-11-26 | 微创医疗器械(上海)有限公司 | 一种药物洗脱介入医疗器械及其制备方法 |
US7148342B2 (en) * | 2002-07-24 | 2006-12-12 | The Trustees Of The University Of Pennyslvania | Compositions and methods for sirna inhibition of angiogenesis |
AU2003301347A1 (en) * | 2002-10-17 | 2004-05-04 | Control Delivery Systems, Inc. | Methods for monitoring treatment of disease |
AU2003301129A1 (en) * | 2002-12-20 | 2004-07-22 | Control Delivery Systems, Inc. | Steroid compositions for intraocular use |
JP2007524349A (ja) | 2003-01-16 | 2007-08-30 | ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア | ICAM−1のsiRNA阻害のための組成物及び方法 |
WO2004066980A2 (en) * | 2003-01-24 | 2004-08-12 | Control Delivery Systems, Inc. | Sustained release device and method for ocular delivery of carbonic anhydrase inhibitors |
CN1741793A (zh) * | 2003-01-24 | 2006-03-01 | 控释给药系统公司 | 高可溶性药物的控制释放 |
SI1592408T1 (sl) * | 2003-01-24 | 2010-01-29 | Psivida Inc | Naprava s podaljšanim sproščanjem in postopek za okularno dajanje adrenergičnih sredstev |
US20050019400A1 (en) * | 2003-01-27 | 2005-01-27 | Deveney Thomas William | Controlled-release drug delivery system |
WO2004073551A2 (en) * | 2003-02-18 | 2004-09-02 | Massachusetts Eye And Ear Infirmary | Transscleral drug delivery device and related methods |
US9445901B2 (en) * | 2003-03-12 | 2016-09-20 | Deger C. Tunc | Prosthesis with sustained release analgesic |
US7037521B2 (en) * | 2003-03-28 | 2006-05-02 | Bausch & Lomb Incorporated | Using a laser for cutting a hole in a capsule for controlled drug delivery |
US20050261668A1 (en) * | 2003-03-28 | 2005-11-24 | Bausch & Lomb Incorporated | Drug delivery device |
US8246974B2 (en) * | 2003-05-02 | 2012-08-21 | Surmodics, Inc. | Medical devices and methods for producing the same |
JP4824549B2 (ja) * | 2003-05-02 | 2011-11-30 | サーモディクス,インコーポレイティド | 制御放出型の生体活性物質デリバリー・デバイス |
US7825134B2 (en) * | 2003-05-19 | 2010-11-02 | Othera Holding, Inc. | Amelioration of cataracts, macular degeneration and other ophthalmic diseases |
US7589107B2 (en) | 2003-05-19 | 2009-09-15 | Othera Holding, Inc. | Amelioration of vitrectomy-induced cataracts |
WO2005000268A2 (en) * | 2003-06-26 | 2005-01-06 | Control Delivery Systems, Inc. | Bioerodible sustained release drug delivery systems |
WO2005000278A1 (en) * | 2003-06-26 | 2005-01-06 | Mediolanum Pharmaceuticals Ltd. | Subcutaneous implants having limited initial release of the active principle and subsequent linearly varying extended release thereof |
SI1635787T1 (sl) * | 2003-06-26 | 2012-04-30 | Psivida Inc | Bioeredibilni sistemi za oddajanje zdravil z zadrževanim sproščanjem |
US20050048123A1 (en) | 2003-06-26 | 2005-03-03 | Control Delivery System, Inc. | In situ gelling drug delivery system |
US9592258B2 (en) | 2003-06-27 | 2017-03-14 | DePuy Synthes Products, Inc. | Treatment of neurological injury by administration of human umbilical cord tissue-derived cells |
US9572840B2 (en) | 2003-06-27 | 2017-02-21 | DePuy Synthes Products, Inc. | Regeneration and repair of neural tissue using postpartum-derived cells |
US8790637B2 (en) * | 2003-06-27 | 2014-07-29 | DePuy Synthes Products, LLC | Repair and regeneration of ocular tissue using postpartum-derived cells |
US20100158880A1 (en) * | 2008-12-19 | 2010-06-24 | Ethicon, Incorporated | Regeneration and repair of neural tissue following injury |
US8518390B2 (en) | 2003-06-27 | 2013-08-27 | Advanced Technologies And Regenerative Medicine, Llc | Treatment of stroke and other acute neural degenerative disorders via intranasal administration of umbilical cord-derived cells |
US8491883B2 (en) * | 2003-06-27 | 2013-07-23 | Advanced Technologies And Regenerative Medicine, Llc | Treatment of amyotrophic lateral sclerosis using umbilical derived cells |
EP1641914B1 (de) * | 2003-06-27 | 2016-07-20 | DePuy Synthes Products, Inc. | Plazenta postpartum abgeleitete zellen und deren herstellungsmethoden und verwendung |
US7875272B2 (en) | 2003-06-27 | 2011-01-25 | Ethicon, Incorporated | Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells |
US20060223177A1 (en) | 2003-06-27 | 2006-10-05 | Ethicon Inc. | Postpartum cells derived from umbilical cord tissue, and methods of making and using the same |
US20050054586A1 (en) * | 2003-06-30 | 2005-03-10 | Bartels Stephen P. | Treatment of ophthalmic disorders |
US20040265356A1 (en) * | 2003-06-30 | 2004-12-30 | Bausch & Lomb Incorporated | Drug delivery device |
KR20060082792A (ko) * | 2003-07-10 | 2006-07-19 | 알콘, 인코퍼레이티드 | 안과용 약물 전달 장치 |
US7585517B2 (en) * | 2003-09-18 | 2009-09-08 | Macusight, Inc. | Transscleral delivery |
CN1901850B (zh) * | 2003-11-13 | 2012-10-03 | 普西维达公司 | 具有可生物侵蚀基质芯和可生物侵蚀皮的注射用缓释植入剂 |
PL2233112T6 (pl) * | 2003-11-13 | 2014-11-28 | Psivida Inc | Wstrzykiwalny implant o przedłużonym uwalnianiu mający biodegradowalną matrycę i biodegradowalną warstewkę |
EP2052720A3 (de) | 2003-11-20 | 2009-05-06 | Othera Holding, Inc. | Verwendung von mindestens einer Hydroxylamin-Verbindung zur Behandlung einer Augenkrankheit |
US20050148948A1 (en) * | 2003-12-19 | 2005-07-07 | Caputa Steven G. | Sutureless ophthalmic drug delivery system and method |
US20050158365A1 (en) * | 2003-12-22 | 2005-07-21 | David Watson | Drug delivery device with mechanical locking mechanism |
US7211272B2 (en) | 2003-12-22 | 2007-05-01 | Bausch & Lomb Incorporated | Drug delivery device |
US20050137538A1 (en) * | 2003-12-22 | 2005-06-23 | Bausch & Lomb Incorporated | Drug delivery device |
US20050136095A1 (en) * | 2003-12-22 | 2005-06-23 | Brian Levy | Drug delivery device with suture ring |
CA2554424A1 (en) * | 2004-01-26 | 2005-08-11 | Control Delivery Systems, Inc. | Controlled and sustained delivery of nucleic acid-based therapeutic agents |
US20060018949A1 (en) * | 2004-04-07 | 2006-01-26 | Bausch & Lomb Incorporated | Injectable biodegradable drug delivery system |
US20050232972A1 (en) * | 2004-04-15 | 2005-10-20 | Steven Odrich | Drug delivery via punctal plug |
US20110028548A1 (en) * | 2004-04-19 | 2011-02-03 | Strategic Science & Technologies, Llc | Beneficial effects of increasing local blood flow |
US9549895B2 (en) * | 2004-04-23 | 2017-01-24 | Massachusetts Eye And Ear Infirmary | Methods and compositions for preserving the viability of photoreceptor cells |
US20050244465A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Drug delivery systems and methods for treatment of an eye |
US8119154B2 (en) * | 2004-04-30 | 2012-02-21 | Allergan, Inc. | Sustained release intraocular implants and related methods |
CN1964711A (zh) * | 2004-05-25 | 2007-05-16 | 奥特拉药物公司 | 眼睛选择性药物及前体药物 |
WO2006002366A2 (en) * | 2004-06-24 | 2006-01-05 | Surmodics, Inc. | Biodegradable ocular devices, methods and systems |
EP1765336A4 (de) | 2004-06-25 | 2010-03-10 | Univ Johns Hopkins | Angiogenesehemmer |
EP2377569A1 (de) * | 2004-07-02 | 2011-10-19 | QLT Plug Delivery, Inc. | Behandlungsmittelspender und Verfahren zur Abgabe des Behandlungsmittels an das Auge |
WO2006014484A2 (en) | 2004-07-02 | 2006-02-09 | Surmodics, Inc. | Methods and devices for the treatment of ocular conditions |
US7117870B2 (en) * | 2004-07-26 | 2006-10-10 | Clarity Corporation | Lacrimal insert having reservoir with controlled release of medication and method of manufacturing the same |
WO2006078320A2 (en) * | 2004-08-04 | 2006-07-27 | Brookwood Pharmaceuticals, Inc. | Methods for manufacturing delivery devices and devices thereof |
US8246569B1 (en) | 2004-08-17 | 2012-08-21 | California Institute Of Technology | Implantable intraocular pressure drain |
US20160106717A1 (en) | 2004-09-24 | 2016-04-21 | Gen Pharma Holdings LLC | Cai-based systems and methods for the localized treatment of uveitis |
US20060067978A1 (en) * | 2004-09-29 | 2006-03-30 | Bausch & Lomb Incorporated | Process for preparing poly(vinyl alcohol) drug delivery devices |
US20060068012A1 (en) * | 2004-09-29 | 2006-03-30 | Bausch & Lomb Incorporated | Process for preparing poly (vinyl alcohol) drug delivery devices with humidity control |
US20060067980A1 (en) * | 2004-09-30 | 2006-03-30 | Bausch & Lomb Incorporated | Capsule for encasing tablets for surgical insertion into the human body |
US20060067979A1 (en) * | 2004-09-30 | 2006-03-30 | Bausch & Lomb Incorporated | Ophthalmic drug release device for multiple drug release |
KR20080016780A (ko) * | 2004-11-24 | 2008-02-22 | 테라킨 리미티드 | 안내 약물 전달용 임플란트 |
US20070276481A1 (en) * | 2004-12-08 | 2007-11-29 | Renner Steven B | Drug delivery device |
US20060134162A1 (en) * | 2004-12-16 | 2006-06-22 | Larson Christopher W | Methods for fabricating a drug delivery device |
US20060153815A1 (en) * | 2004-12-21 | 2006-07-13 | Agnieszka Seyda | Tissue engineering devices for the repair and regeneration of tissue |
US20060171930A1 (en) * | 2004-12-21 | 2006-08-03 | Agnieszka Seyda | Postpartum cells derived from umbilical cord tissue, and methods of making, culturing, and using the same |
US20060166361A1 (en) * | 2004-12-21 | 2006-07-27 | Agnieszka Seyda | Postpartum cells derived from placental tissue, and methods of making, culturing, and using the same |
US20060134176A1 (en) * | 2004-12-22 | 2006-06-22 | Bausch & Lomb Incorporated | Pharmaceutical delivery system and method of use |
US20060134174A1 (en) * | 2004-12-22 | 2006-06-22 | Bausch & Lomb Incorporated | Pharmaceutical delivery system and method of use |
US20060134175A1 (en) * | 2004-12-22 | 2006-06-22 | Stephen Bartels | Drug eluting pharmaceutical delivery system for treatment of ocular disease and method of use |
WO2006068898A1 (en) * | 2004-12-22 | 2006-06-29 | Bausch & Lomb Incorporated | Reusable drug delivery device |
WO2006071802A2 (en) | 2004-12-23 | 2006-07-06 | Ethicon Incorporated | Treatment of stroke and other acute neural degenerative disorders using postpartum derived cells |
US8663639B2 (en) * | 2005-02-09 | 2014-03-04 | Santen Pharmaceutical Co., Ltd. | Formulations for treating ocular diseases and conditions |
BRPI0607606B1 (pt) * | 2005-02-09 | 2021-06-22 | Santen Pharmaceutical, Co., Ltd. | Formulação líquida |
US8003124B2 (en) * | 2005-04-08 | 2011-08-23 | Surmodics, Inc. | Sustained release implants and methods for subretinal delivery of bioactive agents to treat or prevent retinal disease |
US20060258994A1 (en) * | 2005-05-12 | 2006-11-16 | Avery Robert L | Implantable delivery device for administering pharmacological agents to an internal portion of a body |
WO2006127592A2 (en) * | 2005-05-26 | 2006-11-30 | Othera Pharmaceuticals, Inc. | Use of hydroxylamine derivates for inhibiting vitrectomy-induced cataracts |
US20060292202A1 (en) * | 2005-06-27 | 2006-12-28 | Bausch & Lomb Incorporated | Drug delivery device |
AU2006272497B2 (en) | 2005-07-27 | 2012-07-19 | University Of Florida Research Foundation, Inc. | Small compounds that correct protein misfolding and uses thereof |
EP2182078B1 (de) * | 2005-09-01 | 2012-02-01 | Bristol-Myers Squibb Company | Biomarker und Verfahren zur Bestimmung der Empfindlichkeit gegen VEGFR2 modulator. |
US20070212397A1 (en) * | 2005-09-15 | 2007-09-13 | Roth Daniel B | Pharmaceutical delivery device and method for providing ocular treatment |
WO2007067807A1 (en) * | 2005-12-07 | 2007-06-14 | Alacrity Biosciences, Inc. | Tetracyclines for treating ocular diseases and disorders |
PL1971681T3 (pl) * | 2005-12-16 | 2018-01-31 | Depuy Synthes Products Inc | Kompozycje oraz sposoby do hamowania niepożądanej odpowiedzi immunologicznej w przypadku transplantacji z brakiem zgodności tkankowej |
US20070160588A1 (en) * | 2005-12-28 | 2007-07-12 | Ethicon, Incorporated | Treatment Of Peripheral Vascular Disease Using Postpartum-Derived Cells |
US9125906B2 (en) | 2005-12-28 | 2015-09-08 | DePuy Synthes Products, Inc. | Treatment of peripheral vascular disease using umbilical cord tissue-derived cells |
EP2001438A2 (de) | 2006-02-09 | 2008-12-17 | Macusight, Inc. | Stabile formulierungen sowie verfahren zu ihrer herstellung und verwendung |
US20070203190A1 (en) * | 2006-02-22 | 2007-08-30 | Ghanshyam Patil | Hydroxylamines and derivatives for the inhibition of complement activation |
WO2007106557A2 (en) | 2006-03-14 | 2007-09-20 | University Of Southern California | Mems device for delivery of therapeutic agents |
JP5506378B2 (ja) | 2006-03-23 | 2014-05-28 | 参天製薬株式会社 | 血管透過性に関連する疾患または病気のための製剤および方法 |
US8795711B2 (en) | 2006-03-31 | 2014-08-05 | Mati Therapeutics Inc. | Drug delivery methods, structures, and compositions for nasolacrimal system |
US20090130212A1 (en) * | 2006-05-15 | 2009-05-21 | Physical Pharmaceutica, Llc | Composition and improved method for preparation of small particles |
US20080152654A1 (en) * | 2006-06-12 | 2008-06-26 | Exegenics, Inc., D/B/A Opko Health, Inc. | COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF ANGIOGENESIS |
US9474645B2 (en) * | 2006-06-21 | 2016-10-25 | Johnson & Johnson Vision Care, Inc. | Punctal plugs for the delivery of active agents |
US20080045911A1 (en) * | 2006-06-21 | 2008-02-21 | Borgia Maureen J | Punctal plugs for the delivery of active agents |
US9173773B2 (en) * | 2006-06-21 | 2015-11-03 | Johnson & Johnson Vision Care, Inc. | Punctal plugs for the delivery of active agents |
US20080086101A1 (en) * | 2006-08-25 | 2008-04-10 | David Freilich | Ophthalmic insert |
US7872118B2 (en) * | 2006-09-08 | 2011-01-18 | Opko Ophthalmics, Llc | siRNA and methods of manufacture |
WO2008063639A2 (en) | 2006-11-21 | 2008-05-29 | Massachusetts Eye And Ear Infirmary | Compositions and methods for preserving cells of the eye |
US20080145405A1 (en) * | 2006-12-15 | 2008-06-19 | Kunzler Jay F | Drug delivery devices |
WO2008083118A1 (en) * | 2006-12-26 | 2008-07-10 | Qlt Plug Delivery, Inc. | Drug delivery implants for inhibition of optical defects |
CA2679066A1 (en) | 2007-02-22 | 2008-08-28 | Othera Holding, Inc. | Hydroxylamine compounds and methods of their use |
US20080265343A1 (en) * | 2007-04-26 | 2008-10-30 | International Business Machines Corporation | Field effect transistor with inverted t shaped gate electrode and methods for fabrication thereof |
AU2008296872A1 (en) | 2007-09-07 | 2009-03-12 | Qlt Inc. | Lacrimal implants and related methods |
SG184728A1 (en) | 2007-09-07 | 2012-10-30 | Quadra Logic Tech Inc | Lacrimal implant detection |
ES2533359T3 (es) * | 2007-09-07 | 2015-04-09 | Mati Therapeutics Inc. | Núcleos de fármaco para liberación sostenida de agentes terapéuticos |
WO2009035567A2 (en) * | 2007-09-07 | 2009-03-19 | Qlt Plug Delivery, Inc | Insertion and extraction tools for lacrimal implants |
US9775882B2 (en) * | 2007-09-20 | 2017-10-03 | Medtronic, Inc. | Medical devices and methods including polymers having biologically active agents therein |
AU2008308531B2 (en) * | 2007-10-05 | 2014-04-24 | Ethicon, Incorporated | Repair and regeneration of renal tissue using human umbilical cord tissue-derived cells |
CA2705239C (en) | 2007-11-08 | 2018-09-25 | Alimera Sciences, Inc. | Ocular implantation device |
WO2009085952A1 (en) | 2007-12-20 | 2009-07-09 | Brookwood Pharmaceuticals, Inc. | Process for preparing microparticles having a low residual solvent volume |
JP5542691B2 (ja) | 2007-12-20 | 2014-07-09 | ユニバーシティ オブ サザン カリフォルニア | 治療薬を送達するための装置および方法 |
EP2727616B1 (de) * | 2008-01-03 | 2017-04-26 | University Of Southern California | Implantierbare Wirkstofffreisetzungsvorrichtungen sowie Geräte und Verfahren zum Auffüllen der Vorrichtungen |
RU2010136822A (ru) * | 2008-02-18 | 2012-03-10 | Клт Плаг Диливери, Инк. (Us) | Лакримальные имплантаты и связанные с ними способы |
FR2927798B1 (fr) * | 2008-02-25 | 2011-03-04 | C L Investissements | Procede de fabrication d'un dispositif contraceptif intra-uterin et installation pour la mise en oeuvre de ce procede |
EP2276471B1 (de) | 2008-04-30 | 2018-08-08 | Mati Therapeutics Inc. | Träneneinsatz aus verbundstoff und zugehöriges verfahren |
US9333297B2 (en) | 2008-05-08 | 2016-05-10 | Minipumps, Llc | Drug-delivery pump with intelligent control |
EP2320989B1 (de) * | 2008-05-08 | 2015-03-11 | MiniPumps, LLC | Implantierbare pumpen und kanülen dafür |
US8348897B2 (en) | 2008-05-08 | 2013-01-08 | Minipumps, Llc | Implantable drug-delivery devices, and apparatus and methods for filling the devices |
CN102202708B (zh) * | 2008-05-08 | 2015-01-21 | 迷你泵有限责任公司 | 药物输送泵及其制造方法 |
US9949942B2 (en) * | 2008-05-09 | 2018-04-24 | Mati Therapeutics Inc. | Sustained release delivery of active agents to treat glaucoma and ocular hypertension |
WO2010065834A1 (en) | 2008-12-04 | 2010-06-10 | Opko Ophthalmics, Llc | Compositions and methods for selective inhibition of pro-angiogenic vegf isoforms |
US10179900B2 (en) * | 2008-12-19 | 2019-01-15 | DePuy Synthes Products, Inc. | Conditioned media and methods of making a conditioned media |
AU2009327384B2 (en) | 2008-12-19 | 2014-07-10 | DePuy Synthes Products, LLC | Treatment of lung and pulmonary diseases and disorders |
EP2376019A1 (de) * | 2008-12-19 | 2011-10-19 | QLT, Inc. | Punktionsimplantate zur freisetzung von stoffen und verfahren |
ES2520393T3 (es) * | 2008-12-19 | 2014-11-11 | DePuy Synthes Products, LLC | Células derivadas de tejido del cordón umbilical para tratar dolor neuropático y espasticidad |
US8623395B2 (en) | 2010-01-29 | 2014-01-07 | Forsight Vision4, Inc. | Implantable therapeutic device |
CA3045436A1 (en) | 2009-01-29 | 2010-08-05 | Forsight Vision4, Inc. | Posterior segment drug delivery |
US9636255B2 (en) | 2009-02-13 | 2017-05-02 | Dose Medical Corporation | Uveoscleral drug delivery implant and methods for implanting the same |
CA2752645C (en) * | 2009-02-23 | 2017-10-03 | Qlt Inc. | Lacrimal implants and related methods |
CA2792484C (en) | 2009-03-12 | 2017-10-31 | Delpor, Inc. | Implantable device for long-term delivery of drugs |
US20100247607A1 (en) * | 2009-03-26 | 2010-09-30 | Psivida Us, Inc. | Implantable formulations of bisphosphonic acids |
CN102498204B (zh) | 2009-03-26 | 2015-02-04 | 德普伊新特斯产品有限责任公司 | 人脐带组织细胞作为用于阿尔茨海默病的疗法 |
CA2979355C (en) * | 2009-05-18 | 2023-02-21 | Dose Medical Corporation | Drug eluting ocular implant |
US10206813B2 (en) | 2009-05-18 | 2019-02-19 | Dose Medical Corporation | Implants with controlled drug delivery features and methods of using same |
JP5695035B2 (ja) | 2009-06-03 | 2015-04-01 | フォーサイト・ビジョン5・インコーポレイテッドForsight Vision5,Inc. | 前眼部薬物供給 |
IN2012DN00352A (de) | 2009-06-16 | 2015-08-21 | Bikam Pharmaceuticals Inc | |
US20120130300A1 (en) | 2009-07-14 | 2012-05-24 | Board Of Regents, The Univerity Of Texas System | Therapeutic Methods Using Controlled Delivery Devices Having Zero Order Kinetics |
AU2010284216B2 (en) | 2009-08-18 | 2015-10-15 | Minipumps, Llc | Electrolytic drug-delivery pump with adaptive control |
US8808257B2 (en) * | 2009-08-31 | 2014-08-19 | Johnson & Johnson Vision Care, Inc. | Methods and apparatus for pulsatile release of medicaments from a punctal plug |
RU2012127772A (ru) * | 2009-12-04 | 2014-01-10 | ОПКО ОФТЭЛМИКС, ЭлЭлСи | Композиции и способы для ингибирования vegf |
CA2785468A1 (en) * | 2009-12-23 | 2011-06-30 | Psivida Us, Inc. | Sustained release delivery devices |
US10166142B2 (en) | 2010-01-29 | 2019-01-01 | Forsight Vision4, Inc. | Small molecule delivery with implantable therapeutic device |
EP2555749B1 (de) * | 2010-04-06 | 2016-10-26 | Allergan, Inc. | Retard-depotimplantate für intrakamerale wirkstofffreisetzung |
US20130137642A1 (en) | 2010-04-23 | 2013-05-30 | Demetrios Vavvas | Methods and compositions for preserving photoreceptor and retinal pigment epithelial cells |
WO2011139594A2 (en) * | 2010-04-27 | 2011-11-10 | Medtronic, Inc. | Artificial bursa for intra-articular drug delivery |
WO2011161666A2 (en) * | 2010-06-21 | 2011-12-29 | White Innovation Ltd. | Enclosed liquid capsules |
CA2803923A1 (en) | 2010-06-25 | 2011-12-29 | Ignacio R. Rodriguez | Methods of treatment using sterculic acid |
JP2012025708A (ja) * | 2010-07-27 | 2012-02-09 | Sepa Sigma Inc | 膜透過機構を異にする複数の徐放機構を利用した徐放化局所投与剤 |
HRP20211909T1 (hr) | 2010-08-05 | 2022-03-18 | Forsight Vision4, Inc. | Uređaj za liječenja oka |
PL2600930T3 (pl) | 2010-08-05 | 2021-09-06 | Forsight Vision4, Inc. | Urządzenie wstrzykujące do dostarczania leku |
EP2600876B1 (de) | 2010-08-05 | 2015-04-29 | Forsight Vision4, Inc. | Verfahren und vorrichtung zur verabreichung kombinierter arzneimittel |
CA2807552A1 (en) | 2010-08-06 | 2012-02-09 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
ES2862955T3 (es) | 2010-10-01 | 2021-10-08 | Modernatx Inc | Acidos nucleicos manipulados y métodos de uso de los mismos |
US20140024598A1 (en) | 2010-11-01 | 2014-01-23 | Demetrios Vavvas | Methods and compositions for preserving retinal ganglion cells |
WO2012068549A2 (en) | 2010-11-19 | 2012-05-24 | Forsight Vision4, Inc. | Therapeutic agent formulations for implanted devices |
US8679093B2 (en) | 2010-11-23 | 2014-03-25 | Microchips, Inc. | Multi-dose drug delivery device and method |
US9668915B2 (en) | 2010-11-24 | 2017-06-06 | Dose Medical Corporation | Drug eluting ocular implant |
US20120238994A1 (en) * | 2010-12-22 | 2012-09-20 | Martin Nazzaro | Two-piece injectable drug delivery device with heat-cured seal |
WO2012109673A1 (en) * | 2011-02-11 | 2012-08-16 | Psivida Us, Inc. | Methods of treating macular edema using antiedema therapeutics |
US9919099B2 (en) | 2011-03-14 | 2018-03-20 | Minipumps, Llc | Implantable drug pumps and refill devices therefor |
US9603997B2 (en) | 2011-03-14 | 2017-03-28 | Minipumps, Llc | Implantable drug pumps and refill devices therefor |
US10286146B2 (en) | 2011-03-14 | 2019-05-14 | Minipumps, Llc | Implantable drug pumps and refill devices therefor |
US8710200B2 (en) | 2011-03-31 | 2014-04-29 | Moderna Therapeutics, Inc. | Engineered nucleic acids encoding a modified erythropoietin and their expression |
US10245178B1 (en) | 2011-06-07 | 2019-04-02 | Glaukos Corporation | Anterior chamber drug-eluting ocular implant |
EP2720539B1 (de) | 2011-06-14 | 2018-10-24 | Bikam Pharmaceuticals, Inc. | Opsinbindende liganden, deren zusammensetzungen und anwendungsverfahren |
US20150005254A1 (en) | 2011-06-27 | 2015-01-01 | Massachusetts Eye And Ear Infirmary | Methods for treating ocular inflammatory disorders |
US10398592B2 (en) | 2011-06-28 | 2019-09-03 | Forsight Vision4, Inc. | Diagnostic methods and apparatus |
US9724357B2 (en) | 2011-08-15 | 2017-08-08 | Massachusetts Eye & Ear Infirmary | Methods for preserving photoreceptor cell viability following retinal detachment |
CA2846384C (en) | 2011-08-29 | 2020-12-15 | Qlt Inc. | Sustained release delivery of active agents to treat glaucoma and ocular hypertension |
US9974685B2 (en) | 2011-08-29 | 2018-05-22 | Mati Therapeutics | Drug delivery system and methods of treating open angle glaucoma and ocular hypertension |
US9464124B2 (en) | 2011-09-12 | 2016-10-11 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
CA2848397C (en) | 2011-09-14 | 2022-04-26 | Forsight Vision5, Inc. | Ocular insert apparatus and methods |
LT2755600T (lt) | 2011-09-16 | 2021-04-26 | Forsight Vision4, Inc. | Skysčio pakeitimo aparatas |
WO2013052523A1 (en) | 2011-10-03 | 2013-04-11 | modeRNA Therapeutics | Modified nucleosides, nucleotides, and nucleic acids, and uses thereof |
US20140357570A1 (en) | 2011-10-21 | 2014-12-04 | Massachusetts Eye And Ear Infirmary | Compositions comprising necrosis inhibitors, such as necrostatins, alone or in combination, for promoting axon regeneration and nerve function, thereby treating cns disorders |
EP2771043A4 (de) | 2011-10-28 | 2015-04-29 | Presage Biosciences Inc | Wirkstofffreisetzungsverfahren |
US8685106B2 (en) * | 2011-11-15 | 2014-04-01 | Abraham Lin | Method of a pharmaceutical delivery system for use within a joint replacement |
EP2944628B1 (de) | 2011-11-30 | 2017-01-04 | Bikam Pharmaceuticals, Inc. | Opsinbindende liganden, zusammensetzungen und verfahren zur verwendung |
EP2785178B1 (de) | 2011-12-01 | 2019-05-01 | Bikam Pharmaceuticals, Inc. | Opsinbindende liganden, zusammensetzungen damit und anwendungsverfahren dafür |
CN104114572A (zh) | 2011-12-16 | 2014-10-22 | 现代治疗公司 | 经修饰的核苷、核苷酸和核酸组合物 |
AU2012358810B2 (en) | 2011-12-23 | 2018-03-15 | DePuy Synthes Products, Inc. | Detection of human umbilical cord tissue-derived cells |
WO2013116061A1 (en) | 2012-02-03 | 2013-08-08 | Forsight Vision4, Inc. | Insertion and removal methods and apparatus for therapeutic devices |
US9849018B2 (en) | 2012-02-21 | 2017-12-26 | Allurion Technologies, Inc. | Ingestible delivery systems and methods |
US8974483B2 (en) | 2012-02-21 | 2015-03-10 | Allurion Technologies, Inc. | Methods and devices for deploying and releasing a temporary implant within the body |
US10182932B2 (en) | 2012-02-21 | 2019-01-22 | Allurion Technologies, Inc. | Methods and devices for deploying and releasing a temporary implant within the body |
SG11201404821UA (en) * | 2012-02-21 | 2014-09-26 | Allurion Technologies Inc | Methods and devices for deploying and releasing a temporary implant within the body |
US9878056B2 (en) | 2012-04-02 | 2018-01-30 | Modernatx, Inc. | Modified polynucleotides for the production of cosmetic proteins and peptides |
US9283287B2 (en) | 2012-04-02 | 2016-03-15 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of nuclear proteins |
US9572897B2 (en) | 2012-04-02 | 2017-02-21 | Modernatx, Inc. | Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins |
EP2833920A2 (de) | 2012-04-02 | 2015-02-11 | Moderna Therapeutics, Inc. | Modifizierte polynukleotide zur herstellung von biologischen stoffen und proteinen in zusammenhang mit erkrankungen beim menschen |
US9308355B2 (en) | 2012-06-01 | 2016-04-12 | Surmodies, Inc. | Apparatus and methods for coating medical devices |
US9827401B2 (en) | 2012-06-01 | 2017-11-28 | Surmodics, Inc. | Apparatus and methods for coating medical devices |
WO2014031676A1 (en) * | 2012-08-20 | 2014-02-27 | O-Ray Pharma, Inc. | Process for manufacturing drug delivery formulations |
HUE046128T2 (hu) | 2012-10-26 | 2020-02-28 | Forsight Vision5 Inc | Szemészeti rendszer gyógyszer szembe való késleltetett kibocsátására |
PL2922554T3 (pl) | 2012-11-26 | 2022-06-20 | Modernatx, Inc. | Na zmodyfikowany na końcach |
CA2940513C (en) | 2013-03-11 | 2023-08-15 | University Of Florida Research Foundation, Inc. | Delivery of card protein as therapy for ocular inflammation |
AU2014248707B2 (en) * | 2013-03-12 | 2018-11-22 | Eyepoint Pharmaceuticals Us, Inc. | Drug delivery device comprising silicon-based carrier particles |
WO2014152959A1 (en) | 2013-03-14 | 2014-09-25 | Forsight Vision4, Inc. | Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant |
US10517759B2 (en) | 2013-03-15 | 2019-12-31 | Glaukos Corporation | Glaucoma stent and methods thereof for glaucoma treatment |
WO2014145638A1 (en) | 2013-03-15 | 2014-09-18 | Taris Biomedical, Inc | Drug delivery devices with drug-permeable component and methods |
US8980864B2 (en) | 2013-03-15 | 2015-03-17 | Moderna Therapeutics, Inc. | Compositions and methods of altering cholesterol levels |
AU2014241163B2 (en) | 2013-03-28 | 2018-09-27 | Forsight Vision4, Inc. | Ophthalmic implant for delivering therapeutic substances |
EP3052521A1 (de) | 2013-10-03 | 2016-08-10 | Moderna Therapeutics, Inc. | Polynukleotide zur codierung von low-density-lipoprotein-rezeptor |
WO2015103480A1 (en) | 2014-01-02 | 2015-07-09 | Massachusetts Eye & Ear Infirmary | Treating ocular neovascularization |
WO2015184173A1 (en) * | 2014-05-29 | 2015-12-03 | Dose Medical Corporation | Implants with controlled drug delivery features and methods of using same |
MY182497A (en) | 2014-07-15 | 2021-01-25 | Forsight Vision4 Inc | Ocular implant delivery device and method |
AR101476A1 (es) | 2014-08-07 | 2016-12-21 | Acerta Pharma Bv | Métodos para tratar cánceres, enfermedades inmunes y autoinmunes, y enfermedades inflamatorias en base a la tasa de ocupación de la tirosin quinasa de bruton (btk) y a la tasa de resíntesis de la tirosin quinasa de bruton (btk) |
CA2957548A1 (en) | 2014-08-08 | 2016-02-11 | Forsight Vision4, Inc. | Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof |
AU2015315014B2 (en) * | 2014-09-11 | 2020-04-23 | Eyepoint Pharmaceuticals Us, Inc. | Injector apparatus |
US10507101B2 (en) | 2014-10-13 | 2019-12-17 | W. L. Gore & Associates, Inc. | Valved conduit |
WO2016077371A1 (en) | 2014-11-10 | 2016-05-19 | Forsight Vision4, Inc. | Expandable drug delivery devices and method of use |
WO2016168141A1 (en) | 2015-04-13 | 2016-10-20 | Forsight Vision5, Inc. | Ocular insert composition of semi-crystalline or crystalline pharmaceutically active agent |
WO2016172704A1 (en) | 2015-04-23 | 2016-10-27 | Taris Biomedical Llc | Drug delivery devices with drug-permeable component and methods |
US10206978B2 (en) | 2015-06-08 | 2019-02-19 | Retinal Solutions Llc | Norrin regulation of junction proteins and the use thereof to treat epithelial or endothelial membrane leakage induced edema |
US10669321B2 (en) | 2015-06-08 | 2020-06-02 | Retinal Solutions Llc | Retinal capillary regeneration with synthetic norrin protein |
US10202429B2 (en) | 2015-06-08 | 2019-02-12 | Retinal Solutions Llc | Norrin regulation of cellular production of junction proteins and use to treat retinal vasculature edema |
US11925578B2 (en) | 2015-09-02 | 2024-03-12 | Glaukos Corporation | Drug delivery implants with bi-directional delivery capacity |
US11564833B2 (en) | 2015-09-25 | 2023-01-31 | Glaukos Corporation | Punctal implants with controlled drug delivery features and methods of using same |
US10172740B2 (en) | 2015-11-06 | 2019-01-08 | David E Freilich | Lacrimal stent |
CN114469872A (zh) | 2015-11-12 | 2022-05-13 | 灰色视觉公司 | 用于治疗的聚集性微粒 |
BR112018010063A2 (pt) | 2015-11-20 | 2018-11-13 | Forsight Vision4 Inc | estruturas porosas para dispositivos de administração de medicamento de liberação estendida |
WO2017176886A1 (en) | 2016-04-05 | 2017-10-12 | Forsight Vision4, Inc. | Implantable ocular drug delivery devices |
EP3442479A1 (de) | 2016-04-20 | 2019-02-20 | Harold Alexander Heitzmann | Vorrichtung zur verabreichung eines bioresorbierbaren okularen medikaments |
MX2019000050A (es) | 2016-07-05 | 2019-05-02 | Janssen Biotech Inc | Tratamiento de la enfermedad vascular retinal mediante el uso de celulas progenitoras. |
CN110545836A (zh) | 2017-01-24 | 2019-12-06 | 马克雷根有限公司 | 用载脂蛋白模拟物治疗与年龄有关的黄斑变性和其他眼部疾病 |
US20180296525A1 (en) | 2017-03-03 | 2018-10-18 | Macregen, Inc. | Treatment of age-related macular degeneration and other eye diseases with one or more therapeutic agents |
US11523940B2 (en) | 2017-03-17 | 2022-12-13 | W. L. Gore & Associates, Inc. | Delivery aids for glaucoma shunts |
BR112019019452A2 (pt) | 2017-03-23 | 2020-04-14 | Graybug Vision Inc | composto, e, uso de um composto |
US11160870B2 (en) | 2017-05-10 | 2021-11-02 | Graybug Vision, Inc. | Extended release microparticles and suspensions thereof for medical therapy |
JP2020528082A (ja) | 2017-07-17 | 2020-09-17 | ロイズマン,キース | 加齢黄斑変性と他の眼疾患の治療用の細胞透過性ペプチドを使用する治療薬の局所送達 |
WO2019023617A1 (en) * | 2017-07-27 | 2019-01-31 | University Of Utah Research Foundation | DEVICE FOR DELIVERY OF THERAPEUTIC PRODUCT |
CA3082891A1 (en) | 2017-11-21 | 2019-05-31 | Forsight Vision4, Inc. | Fluid exchange apparatus for expandable port delivery system and methods of use |
WO2019165449A1 (en) | 2018-02-26 | 2019-08-29 | Allurion Technologies, Inc. | Automatic-sealing balloon-filling catheter system |
KR20210013089A (ko) | 2018-05-24 | 2021-02-03 | 셀라니즈 이브이에이 퍼포먼스 폴리머스 엘엘씨 | 거대 분자 약물 화합물의 지속적인 방출을 위한 이식가능 장치 |
EP3801462A4 (de) | 2018-05-24 | 2022-03-16 | Celanese EVA Performance Polymers LLC | Implantierbare vorrichtung zur verzögerten freisetzung einer makromolekularen wirkstoffverbindung |
CN114376777B (zh) | 2018-07-06 | 2024-02-02 | 安瑞仁科技公司 | 二元流体控制阀系统 |
WO2020035819A1 (en) * | 2018-08-15 | 2020-02-20 | Microsert Ltd. | Sustained release component and corresponding drug delivery device with biodegradable material for flow path modification |
CN109172963B (zh) * | 2018-10-19 | 2021-05-14 | 青岛大学附属医院 | 具有连续给药功能的雾化理疗器 |
WO2020112816A1 (en) | 2018-11-29 | 2020-06-04 | Surmodics, Inc. | Apparatus and methods for coating medical devices |
US11678983B2 (en) | 2018-12-12 | 2023-06-20 | W. L. Gore & Associates, Inc. | Implantable component with socket |
EP3886774A4 (de) | 2018-12-13 | 2022-09-28 | Allurion Technologies, Inc. | Verbessertes fluidausgabesystem |
US11039954B2 (en) | 2019-03-21 | 2021-06-22 | Microoptx Inc. | Implantable ocular drug delivery devices and methods |
CN110046067B (zh) * | 2019-04-22 | 2023-10-31 | 无线生活(杭州)信息科技有限公司 | 接口测试方法及装置 |
US11819590B2 (en) | 2019-05-13 | 2023-11-21 | Surmodics, Inc. | Apparatus and methods for coating medical devices |
CA3149866A1 (en) | 2019-10-24 | 2021-04-29 | Denis E. Labombard | Ocular device and drug delivery system, with case |
WO2023031277A1 (en) | 2021-08-31 | 2023-03-09 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for the treatment of ocular rosacea |
Family Cites Families (195)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3416350A (en) | 1966-02-23 | 1968-12-17 | Martin Marietta Corp | Gripping structure |
US3416530A (en) | 1966-03-02 | 1968-12-17 | Richard A. Ness | Eyeball medication dispensing tablet |
US3854480A (en) * | 1969-04-01 | 1974-12-17 | Alza Corp | Drug-delivery system |
US3896819A (en) | 1969-04-01 | 1975-07-29 | Alejandro Zaffaroni | IUD having a replenishing drug reservoir |
US3630200A (en) | 1969-06-09 | 1971-12-28 | Alza Corp | Ocular insert |
US3618604A (en) | 1969-06-09 | 1971-11-09 | Alza Corp | Ocular insert |
US3632739A (en) | 1969-12-29 | 1972-01-04 | Sandoz Ag | Solid sustained release pharmaceutical preparation |
US3980463A (en) | 1970-11-16 | 1976-09-14 | Sumitomo Chemical Company, Limited | Process for producing granular composition for use in agriculture and horticulture |
US3829570A (en) * | 1971-01-26 | 1974-08-13 | Boehringer Sohn Ingelheim | Therapeutic compositions and method |
US3993071A (en) | 1971-09-09 | 1976-11-23 | Alza Corporation | Bioerodible ocular device |
US3948254A (en) * | 1971-11-08 | 1976-04-06 | Alza Corporation | Novel drug delivery device |
US3828777A (en) | 1971-11-08 | 1974-08-13 | Alza Corp | Microporous ocular device |
US3892570A (en) * | 1972-04-18 | 1975-07-01 | Xerox Corp | Light activating imaging process |
US4036227A (en) | 1973-04-25 | 1977-07-19 | Alza Corporation | Osmotic releasing device having a plurality of release rate patterns |
US3916899A (en) | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
US4177256A (en) | 1973-04-25 | 1979-12-04 | Alza Corporation | Osmotic bursting drug delivery device |
US4351337A (en) | 1973-05-17 | 1982-09-28 | Arthur D. Little, Inc. | Biodegradable, implantable drug delivery device, and process for preparing and using the same |
US3914402A (en) | 1973-06-14 | 1975-10-21 | Alza Corp | Ophthalmic dosage form, for releasing medication over time |
US3961628A (en) | 1974-04-10 | 1976-06-08 | Alza Corporation | Ocular drug dispensing system |
US4096238A (en) | 1974-12-23 | 1978-06-20 | Alza Corporation | Method for administering drug to the gastrointestinal tract |
US4014335A (en) | 1975-04-21 | 1977-03-29 | Alza Corporation | Ocular drug delivery device |
US4014355A (en) | 1975-08-11 | 1977-03-29 | Dynell Electronics Corporation | Bidet and hygienic cleansing arrangement |
US4034758A (en) | 1975-09-08 | 1977-07-12 | Alza Corporation | Osmotic therapeutic system for administering medicament |
US3977404A (en) | 1975-09-08 | 1976-08-31 | Alza Corporation | Osmotic device having microporous reservoir |
US4077407A (en) | 1975-11-24 | 1978-03-07 | Alza Corporation | Osmotic devices having composite walls |
US4008719A (en) | 1976-02-02 | 1977-02-22 | Alza Corporation | Osmotic system having laminar arrangement for programming delivery of active agent |
US4014334A (en) | 1976-02-02 | 1977-03-29 | Alza Corporation | Laminated osmotic system for dispensing beneficial agent |
US4247498A (en) | 1976-08-30 | 1981-01-27 | Akzona Incorporated | Methods for making microporous products |
US4111203A (en) | 1976-11-22 | 1978-09-05 | Alza Corporation | Osmotic system with means for improving delivery kinetics of system |
US4111201A (en) | 1976-11-22 | 1978-09-05 | Alza Corporation | Osmotic system for delivering selected beneficial agents having varying degrees of solubility |
US4256108A (en) | 1977-04-07 | 1981-03-17 | Alza Corporation | Microporous-semipermeable laminated osmotic system |
US4519909A (en) | 1977-07-11 | 1985-05-28 | Akzona Incorporated | Microporous products |
US4186184A (en) | 1977-12-27 | 1980-01-29 | Alza Corporation | Selective administration of drug with ocular therapeutic system |
JPS54119021A (en) | 1978-03-06 | 1979-09-14 | Nippon Kayaku Co Ltd | Carcinostatic agent |
US4290426A (en) | 1978-05-04 | 1981-09-22 | Alza Corporation | Dispenser for dispensing beneficial agent |
US4260736A (en) * | 1978-08-14 | 1981-04-07 | Kureha Kagaku Kogyo Kabushiki Kaisha | Steroid hormone-antitumor derivatives |
US4200098A (en) | 1978-10-23 | 1980-04-29 | Alza Corporation | Osmotic system with distribution zone for dispensing beneficial agent |
US4304232A (en) | 1979-03-14 | 1981-12-08 | Alza Corporation | Unit system having multiplicity of means for dispensing useful agent |
US4283394A (en) * | 1979-08-06 | 1981-08-11 | Research Corporation | Cytotoxic nucleoside-corticosteroid phosphodiesters |
US4304765A (en) | 1980-10-14 | 1981-12-08 | Alza Corporation | Ocular insert housing steroid in two different therapeutic forms |
US4326525A (en) | 1980-10-14 | 1982-04-27 | Alza Corporation | Osmotic device that improves delivery properties of agent in situ |
US4322323A (en) | 1980-12-01 | 1982-03-30 | Alza Corporation | Erodible device comprising surfactant for modifying the rate of erosion of the device |
US4327725A (en) | 1980-11-25 | 1982-05-04 | Alza Corporation | Osmotic device with hydrogel driving member |
US4484922A (en) | 1981-06-25 | 1984-11-27 | Rosenwald Peter L | Occular device |
JPS5835110A (ja) | 1981-08-28 | 1983-03-01 | Tetsuo Kato | 徐放性マイクロカプセル |
US4730013A (en) | 1981-10-08 | 1988-03-08 | Merck & Co., Inc. | Biosoluble ocular insert |
US4439196A (en) | 1982-03-18 | 1984-03-27 | Merck & Co., Inc. | Osmotic drug delivery system |
US4475916A (en) | 1982-03-18 | 1984-10-09 | Merck & Co., Inc. | Osmotic drug delivery system |
DK90883A (da) | 1982-03-18 | 1983-09-19 | Merck & Co Inc | Beholder til osmotisk afgivelse af et stof eller en stofblanding |
US4432965A (en) | 1982-07-09 | 1984-02-21 | Key Pharmaceuticals, Inc. | Quinidine sustained release dosage formulation |
US4519801A (en) | 1982-07-12 | 1985-05-28 | Alza Corporation | Osmotic device with wall comprising cellulose ether and permeability enhancer |
US4522625A (en) | 1982-09-29 | 1985-06-11 | Alza Corporation | Drug dispenser comprising wall formed of semipermeable member and enteric member |
US4478818A (en) | 1982-12-27 | 1984-10-23 | Alza Corporation | Ocular preparation housing steroid in two different therapeutic forms |
US4673405A (en) | 1983-03-04 | 1987-06-16 | Alza Corporation | Osmotic system with instant drug availability |
US4627850A (en) | 1983-11-02 | 1986-12-09 | Alza Corporation | Osmotic capsule |
JPS60100516A (ja) | 1983-11-04 | 1985-06-04 | Takeda Chem Ind Ltd | 徐放型マイクロカプセルの製造法 |
US4777049A (en) | 1983-12-01 | 1988-10-11 | Alza Corporation | Constant release system with pulsed release |
EP0147780A3 (de) | 1984-01-03 | 1987-03-11 | Merck & Co. Inc. | Vorrichtung zur Freisetzung von Arzneistoffen |
IT1206166B (it) | 1984-07-26 | 1989-04-14 | Sigma Tau Ind Farmaceuti | Dispositivo per rilasciare una sostanza in un fluido di dissoluzione con cinetica di ordine zero e procedimento per la sua preparazione |
US4692336A (en) | 1984-03-19 | 1987-09-08 | Alza Corporation | Self controlled release device for administering beneficial agent to recipient |
US4716031A (en) | 1984-03-21 | 1987-12-29 | Alza Corporation | Drug dispenser comprising a multiplicity of members acting together for successfully dispensing drug |
US4615698A (en) | 1984-03-23 | 1986-10-07 | Alza Corporation | Total agent osmotic delivery system |
DE3580384D1 (de) | 1984-04-09 | 1990-12-13 | Toyo Boseki | Praeparat mit verzoegerter freigabe zum aufbringen auf die schleimhaeute der mundhoehle. |
US4657543A (en) | 1984-07-23 | 1987-04-14 | Massachusetts Institute Of Technology | Ultrasonically modulated polymeric devices for delivering compositions |
US4743247A (en) | 1984-08-13 | 1988-05-10 | Alza Corporation | Process for manufacturing dosage form |
US4927687A (en) | 1984-10-01 | 1990-05-22 | Biotek, Inc. | Sustained release transdermal drug delivery composition |
IE58110B1 (en) | 1984-10-30 | 1993-07-14 | Elan Corp Plc | Controlled release powder and process for its preparation |
US4863735A (en) | 1985-02-19 | 1989-09-05 | Massachusetts Institute Of Technology | Biodegradable polymeric drug delivery system with adjuvant activity |
US4913906B1 (en) | 1985-02-28 | 2000-06-06 | Yissum Res Dev Co | Controlled release dosage form of valproic acid |
US4624847A (en) | 1985-04-22 | 1986-11-25 | Alza Corporation | Drug delivery device for programmed delivery of beneficial drug |
US4609374A (en) | 1985-04-22 | 1986-09-02 | Alza Corporation | Osmotic device comprising means for governing initial time of agent release therefrom |
US4693886A (en) | 1985-04-22 | 1987-09-15 | Alza Corporation | Osmotic device with inert core |
US4720384A (en) | 1985-05-03 | 1988-01-19 | E. I. Du Pont De Nemours And Company | Manufacture of hollow fine tubular drug delivery systems |
JPS6210381A (ja) | 1985-07-08 | 1987-01-19 | 大成建設株式会社 | 空気膜構造物における膜面接合装置 |
US4898733A (en) | 1985-11-04 | 1990-02-06 | International Minerals & Chemical Corp. | Layered, compression molded device for the sustained release of a beneficial agent |
US4717567A (en) | 1985-11-25 | 1988-01-05 | Eastman Kodak Company | Rumen-stable pellets |
IT1188212B (it) | 1985-12-20 | 1988-01-07 | Paolo Colombo | Sistema per il rilascio a velocita' controllata di sostanze attive |
US4764364A (en) | 1986-02-25 | 1988-08-16 | S R I International | Method of preparing bioerodible polymers having pH sensitivity in the acid range and resulting product |
US4814323A (en) | 1986-03-25 | 1989-03-21 | Andrieu J M | Process for the treatment and the prevention of AIDS and other disorders induced by the LAV/HTLV III virus |
AU605482B2 (en) * | 1986-04-17 | 1991-01-17 | Castex Products Limited | Pellet for administration to ruminants |
US5141752A (en) | 1986-05-09 | 1992-08-25 | Alza Corporation | Delayed drug delivery device |
US5342622A (en) | 1986-05-16 | 1994-08-30 | The State Of Victoria | Subdermal biocompatible implants |
US4959217A (en) | 1986-05-22 | 1990-09-25 | Syntex (U.S.A.) Inc. | Delayed/sustained release of macromolecules |
US4832957A (en) | 1987-12-11 | 1989-05-23 | Merck & Co., Inc. | Controlled release combination of carbidopa/levodopa |
US4786500A (en) | 1986-06-26 | 1988-11-22 | Alza Corporation | Programmable agent delivery system |
US4927632A (en) | 1986-06-26 | 1990-05-22 | Alza Corporation | Selective pulsed drug delivery system |
JPH0794384B2 (ja) | 1986-09-01 | 1995-10-11 | 帝国製薬株式会社 | 徐放性口腔内用製剤 |
US5147647A (en) | 1986-10-02 | 1992-09-15 | Sohrab Darougar | Ocular insert for the fornix |
US4830860A (en) | 1986-10-30 | 1989-05-16 | Pfizer Inc. | Stressed polymeric device for controlled release of a substance to an ambient environment |
HU205861B (en) | 1986-12-19 | 1992-07-28 | Sandoz Ag | Process for producing hydrosole of pharmaceutically effective material |
US4806382A (en) | 1987-04-10 | 1989-02-21 | University Of Florida | Ocular implants and methods for their manufacture |
US4861627A (en) | 1987-05-01 | 1989-08-29 | Massachusetts Institute Of Technology | Preparation of multiwall polymeric microcapsules |
US4789513A (en) | 1987-06-05 | 1988-12-06 | P.C.E. Corp. | Coextrusion apparatus and process |
DE3879031T2 (de) | 1987-08-08 | 1993-06-24 | Akzo Nv | Kontrazeptives implantat. |
DE3851152T2 (de) | 1987-09-03 | 1995-01-26 | Univ Georgia Res Found | Cyclosporin-augenmittel. |
US4891223A (en) | 1987-09-03 | 1990-01-02 | Air Products And Chemicals, Inc. | Controlled release delivery coating formulation for bioactive substances |
US4839342A (en) | 1987-09-03 | 1989-06-13 | University Of Georgia Research Foundation, Inc. | Method of increasing tear production by topical administration of cyclosporin |
US5035891A (en) * | 1987-10-05 | 1991-07-30 | Syntex (U.S.A.) Inc. | Controlled release subcutaneous implant |
SE8703881D0 (sv) | 1987-10-08 | 1987-10-08 | Haessle Ab | New pharmaceutical preparation |
US4994273A (en) | 1987-11-02 | 1991-02-19 | Merck & Co., Inc. | Solubility modulated drug delivery device |
IT1223150B (it) | 1987-11-18 | 1990-09-12 | Ubaldo Conte | Compressa per uso oftalmico e rilascio controllato della sostanza attiva |
US4945089A (en) * | 1987-12-29 | 1990-07-31 | Alcon Laboratories, Inc. | Use of tetrahydrocortexolone to prevent elevations in intraocular pressure caused by corticosteroids |
US4877618A (en) | 1988-03-18 | 1989-10-31 | Reed Jr Fred D | Transdermal drug delivery device |
AU3432689A (en) * | 1988-03-24 | 1989-10-16 | Bukh Meditec A/S | Controlled release composition |
US4882150A (en) | 1988-06-03 | 1989-11-21 | Kaufman Herbert E | Drug delivery system |
US4865846A (en) | 1988-06-03 | 1989-09-12 | Kaufman Herbert E | Drug delivery system |
US4946456A (en) * | 1988-08-26 | 1990-08-07 | Alza Corp. | Fluid imbibing pump activated by capillary action of a fabric or polymeric sleeve |
US5124392A (en) | 1988-10-03 | 1992-06-23 | Alcon Laboratories, Inc. | Pharmaceutical compositions and methods of treatment to prevent and treat corneal scar formation produced by laser irradiation |
US5360611A (en) | 1988-10-03 | 1994-11-01 | Alcon Laboratories, Inc. | Pharmaceutical compositions and methods of treatment of the cornea following ultraviolet laser irradiation |
US5306500A (en) | 1988-11-21 | 1994-04-26 | Collagen Corporation | Method of augmenting tissue with collagen-polymer conjugates |
US5174999A (en) | 1988-12-13 | 1992-12-29 | Alza Corporation | Delivery system comprising fluid ingress and drug egress |
DD295760A5 (de) | 1989-01-31 | 1991-11-14 | Martin-Luther-Universitaet Halle Wittenberg,De | Arzneistoffreigabesystem mit kotrollierter wirkstoffreisetzung |
US5098443A (en) | 1989-03-23 | 1992-03-24 | University Of Miami | Method of implanting intraocular and intraorbital implantable devices for the controlled release of pharmacological agents |
FR2645029B1 (fr) | 1989-03-28 | 1997-09-12 | Cordis Sa | Membrane de reservoir implantable sous la peau d'un patient |
US5028435A (en) | 1989-05-22 | 1991-07-02 | Advanced Polymer Systems, Inc. | System and method for transdermal drug delivery |
DK469989D0 (da) * | 1989-09-22 | 1989-09-22 | Bukh Meditec | Farmaceutisk praeparat |
US5120548A (en) | 1989-11-07 | 1992-06-09 | Merck & Co., Inc. | Swelling modulated polymeric drug delivery device |
US5294604A (en) | 1989-12-20 | 1994-03-15 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Method of treating ocular diseases by periocular administration of cyclosporine A or G |
WO1991011176A1 (en) | 1990-01-30 | 1991-08-08 | Akzo N.V. | Article for the controlled delivery of an active substance, comprising a hollow space fully enclosed by a wall and filled in full or in part with one or more active substances |
US5201764A (en) | 1990-02-28 | 1993-04-13 | Autogenesis Technologies, Inc. | Biologically compatible collagenous reaction product and articles useful as medical implants produced therefrom |
US5178866A (en) | 1990-03-23 | 1993-01-12 | Alza Corporation | Dosage form for delivering drug to the intestine |
US5324280A (en) | 1990-04-02 | 1994-06-28 | Alza Corporation | Osmotic dosage system for delivering a formulation comprising liquid carrier and drug |
US5156623A (en) | 1990-04-16 | 1992-10-20 | Olympus Optical Co., Ltd. | Sustained release material and method of manufacturing the same |
US5091185A (en) | 1990-06-20 | 1992-02-25 | Monsanto Company | Coated veterinary implants |
GR1001529B (el) | 1990-09-07 | 1994-03-31 | Elmuquimica Farm Sl | Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης. |
JP2701977B2 (ja) | 1990-09-28 | 1998-01-21 | ファイザー インク | 疎水性媒体を含有する投薬体 |
IS3778A7 (is) | 1990-10-31 | 1992-05-02 | Amgen Inc. | Aðferð til að gefa dýrum vaxtarhormón, þar sem gefnu magni er stýrt |
US5378475A (en) * | 1991-02-21 | 1995-01-03 | University Of Kentucky Research Foundation | Sustained release drug delivery devices |
NZ286242A (en) | 1991-03-26 | 1997-11-24 | Csl Ltd | Use of veterinary implant as a single dose vaccination system: rupturable polymer film coating around core of active agent and water soluble excipient |
US5226902A (en) | 1991-07-30 | 1993-07-13 | University Of Utah | Pulsatile drug delivery device using stimuli sensitive hydrogel |
DE69227777T2 (de) | 1991-08-23 | 1999-05-27 | Gillette Co | Matrizen mit verzögerter freisetzung für dentalzwecke |
FR2682090B1 (fr) | 1991-10-03 | 1993-12-31 | Holzstoff Holding Sa | Systeme-reservoir pour diffusion prolongee d'un principe actif. |
US5178635A (en) | 1992-05-04 | 1993-01-12 | Allergan, Inc. | Method for determining amount of medication in an implantable device |
US5512293A (en) * | 1992-07-23 | 1996-04-30 | Alza Corporation | Oral sustained release drug delivery device |
US5314419A (en) * | 1992-10-30 | 1994-05-24 | Pelling George E | Method for dispensing ophthalmic drugs to the eye |
US5840881A (en) * | 1992-11-27 | 1998-11-24 | Takeda Chemical Industries, Ltd. | Composition containing a water-insoluble or slightly water-soluble compound with enhanced water-solubility |
US5538735A (en) | 1993-02-19 | 1996-07-23 | Ahn; Sam S. | Method of making a drug delivery system using hollow fibers |
US5393536A (en) | 1993-04-05 | 1995-02-28 | Crane Plastics Company | Coextrusion apparatus |
WO1995003807A1 (en) | 1993-07-27 | 1995-02-09 | The University Of Sydney | Treatment of age-related macular degeneration |
JPH0748246A (ja) | 1993-08-06 | 1995-02-21 | Fujisawa Pharmaceut Co Ltd | 徐放性注入剤 |
DE69430824T2 (de) | 1993-08-12 | 2003-01-23 | Neurotech Sa | Biokompatible immunoisolatorische Kapseln, die genetisch veränderte Zellen enthalten |
US5443505A (en) | 1993-11-15 | 1995-08-22 | Oculex Pharmaceuticals, Inc. | Biocompatible ocular implants |
JP3720386B2 (ja) | 1993-12-27 | 2005-11-24 | 住友製薬株式会社 | 薬物放出制御製剤 |
AU705226B2 (en) | 1994-01-28 | 1999-05-20 | University Of Kentucky Research Foundation, The | Codrugs as a method of controlled drug delivery |
US6051576A (en) * | 1994-01-28 | 2000-04-18 | University Of Kentucky Research Foundation | Means to achieve sustained release of synergistic drugs by conjugation |
US5474979A (en) | 1994-05-17 | 1995-12-12 | Allergan, Inc. | Nonirritating emulsions for sensitive tissue |
WO1995035131A1 (en) | 1994-06-22 | 1995-12-28 | Unasco Pty. Ltd. | Controlled release device and method |
US5435998A (en) | 1994-08-03 | 1995-07-25 | Abelson; Mark B. | Treatment of low-tension glaucoma by topical administration of calcium channel blocking agents |
KR100201352B1 (ko) | 1995-03-16 | 1999-06-15 | 성재갑 | 단일주사 백신 제형 |
US5569429A (en) | 1995-05-05 | 1996-10-29 | Randcastle Extrusion Systems, Inc. | Dynamic seal and sealing method |
US5554187A (en) | 1995-08-18 | 1996-09-10 | Rizzo, Iii; Joseph | Medication dispensing intra-ocular lens system |
US5773019A (en) * | 1995-09-27 | 1998-06-30 | The University Of Kentucky Research Foundation | Implantable controlled release device to deliver drugs directly to an internal portion of the body |
US6283951B1 (en) | 1996-10-11 | 2001-09-04 | Transvascular, Inc. | Systems and methods for delivering drugs to selected locations within the body |
US6039975A (en) * | 1995-10-17 | 2000-03-21 | Hoffman-La Roche Inc. | Colon targeted delivery system |
DE19539361A1 (de) | 1995-10-23 | 1997-04-24 | Basf Ag | Verfahren zur Herstellung von mehrschichtigen, festen Arzneiformen zur oralen oder rektalen Verabreichung |
US6441047B2 (en) | 1995-11-17 | 2002-08-27 | Alcon Manufacturing Ltd.. | Combination therapy for treating glaucoma |
US5797898A (en) * | 1996-07-02 | 1998-08-25 | Massachusetts Institute Of Technology | Microchip drug delivery devices |
ZA981610B (en) * | 1997-03-24 | 1999-08-26 | Alza Corp | Self adjustable exit port. |
PT973499E (pt) * | 1997-03-31 | 2003-12-31 | Alza Corp | Sistema de administracao difusor implantavel |
IL123813A0 (en) * | 1997-04-11 | 1998-10-30 | Akzo Nobel Nv | Drug delivery system for two or more active substances |
FR2766088B1 (fr) | 1997-07-17 | 2001-01-05 | Dow Corning Sa | Dispositifs a liberation controlee d'un agent pharmaceutique, leur fabrication par co-extrusion et article intermediaire |
US6055453A (en) | 1997-08-01 | 2000-04-25 | Genetronics, Inc. | Apparatus for addressing needle array electrodes for electroporation therapy |
US5902598A (en) * | 1997-08-28 | 1999-05-11 | Control Delivery Systems, Inc. | Sustained release drug delivery devices |
JP3240593B2 (ja) | 1998-02-16 | 2001-12-17 | 株式会社高研 | 可溶性コラーゲンパウダーを担体とする医薬徐放剤 |
US6267154B1 (en) | 1998-06-05 | 2001-07-31 | Abbott Laboratories | System for storing mixing and administering a drug |
US6217895B1 (en) * | 1999-03-22 | 2001-04-17 | Control Delivery Systems | Method for treating and/or preventing retinal diseases with sustained release corticosteroids |
US6368658B1 (en) | 1999-04-19 | 2002-04-09 | Scimed Life Systems, Inc. | Coating medical devices using air suspension |
US6606992B1 (en) | 1999-06-30 | 2003-08-19 | Nektar Therapeutics | Systems and methods for aerosolizing pharmaceutical formulations |
US20030105121A1 (en) | 1999-07-27 | 2003-06-05 | Bernard Bihari | Method of preventing lipodystrophy syndrome or reversing a pre-existing syndrome in HIV-infected patients being treated with antiretroviral agents |
US6491683B1 (en) | 1999-09-07 | 2002-12-10 | Alza Corporation | Osmotic dosage form composed of an extruded polymer tube form |
US6267058B1 (en) * | 1999-10-01 | 2001-07-31 | Flight Rail Corporation | Coupling mechanism for magnetically coupled transportation module |
CA2544460C (en) | 1999-10-22 | 2009-04-07 | Allergan, Inc. | Controlled-release biocompatible ocular drug delivery implant devices and methods |
US6331313B1 (en) * | 1999-10-22 | 2001-12-18 | Oculex Pharmaceticals, Inc. | Controlled-release biocompatible ocular drug delivery implant devices and methods |
KR100416242B1 (ko) | 1999-12-22 | 2004-01-31 | 주식회사 삼양사 | 약물전달체용 생분해성 블록 공중합체의 액체 조성물 및이의 제조방법 |
US6375972B1 (en) | 2000-04-26 | 2002-04-23 | Control Delivery Systems, Inc. | Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
US20040115268A1 (en) | 2000-04-26 | 2004-06-17 | Control Delivery Systems, Inc. | Systemic delivery of antiviral agents |
US6242058B1 (en) | 2000-05-12 | 2001-06-05 | Dow Corning Corporation | Method for forming coatings from radiation curable compositions containing alkenyl ether functional polyisobutylenes |
WO2002005788A1 (en) | 2000-07-14 | 2002-01-24 | Universiteit Gent | Composite solid shaped articles for the controlled delivery of biologically active ingredients |
DE60110192T2 (de) | 2000-12-07 | 2006-03-09 | Warner-Lambert Company Llc | Verfahren und System zur gleichmäßigen Arzneistoffabgabe |
WO2002087586A1 (en) | 2001-04-26 | 2002-11-07 | Control Delivery Systems, Inc. | Sustained release drug delivery system containing codrugs |
EP1387671A1 (de) | 2001-05-03 | 2004-02-11 | MASSACHUSETTS EYE & EAR INFIRMARY | Implantierbare arzneistoffverabreichungsvorrichtung und verwendung derselben |
AU2002324447B2 (en) | 2001-06-22 | 2006-06-29 | Durect Corporation | Zero-order prolonged release coaxial implants |
AUPR602401A0 (en) | 2001-06-29 | 2001-07-26 | Smart Drug Systems Inc | Sustained release delivery system |
WO2003051328A1 (en) | 2001-12-18 | 2003-06-26 | Novo Nordisk A/S | Solid dose micro implant |
US8084020B2 (en) | 2002-05-01 | 2011-12-27 | Beth Israel Deaconess Medical Center | Use of anti-CD1 antibodies for the modulation of immune responses |
US8871241B2 (en) | 2002-05-07 | 2014-10-28 | Psivida Us, Inc. | Injectable sustained release delivery devices |
MXPA04011004A (es) * | 2002-05-07 | 2005-01-25 | Control Delivery Sys Inc | Procesos para formar un dispositivo de administracion de farmaco. |
WO2004043435A2 (en) | 2002-11-13 | 2004-05-27 | Control Delivery Systems, Inc. | Systemic delivery of antiviral agents |
PL2233112T6 (pl) | 2003-11-13 | 2014-11-28 | Psivida Inc | Wstrzykiwalny implant o przedłużonym uwalnianiu mający biodegradowalną matrycę i biodegradowalną warstewkę |
CA2554424A1 (en) | 2004-01-26 | 2005-08-11 | Control Delivery Systems, Inc. | Controlled and sustained delivery of nucleic acid-based therapeutic agents |
US8147865B2 (en) | 2004-04-30 | 2012-04-03 | Allergan, Inc. | Steroid-containing sustained release intraocular implants and related methods |
US8119154B2 (en) | 2004-04-30 | 2012-02-21 | Allergan, Inc. | Sustained release intraocular implants and related methods |
JP5745208B2 (ja) | 2005-10-18 | 2015-07-08 | アラーガン インコーポレイテッドAllergan,Incorporated | 後区組織に選択的に浸透するグルココルチコイド誘導体を用いた眼治療 |
WO2008070479A2 (en) | 2006-12-01 | 2008-06-12 | Allergan, Inc. | Method for determining optimum intraocular locations for drug delivery systems |
EP2515911A4 (de) | 2009-12-23 | 2013-08-07 | Alimera Sciences Inc | Verfahren zur verringerung des auftretens von intraokularem druck im zusammenhang mit der intraokularen anwendung von kortikosteroiden |
-
2000
- 2000-04-26 US US09/558,207 patent/US6375972B1/en not_active Expired - Lifetime
-
2001
- 2001-04-19 AU AU2001253675A patent/AU2001253675B2/en not_active Expired
- 2001-04-19 AU AU5367501A patent/AU5367501A/xx active Pending
- 2001-04-19 EP EP08161489A patent/EP1982701A3/de not_active Withdrawn
- 2001-04-19 NZ NZ531721A patent/NZ531721A/en not_active IP Right Cessation
- 2001-04-19 SI SI200130887T patent/SI1276462T1/sl unknown
- 2001-04-19 WO PCT/US2001/012700 patent/WO2001080825A2/en active IP Right Grant
- 2001-04-19 CN CN01811703A patent/CN1438873A/zh active Pending
- 2001-04-19 KR KR1020027014204A patent/KR100854541B1/ko active IP Right Grant
- 2001-04-19 MX MXPA02010442A patent/MXPA02010442A/es active IP Right Grant
- 2001-04-19 DK DK01927200T patent/DK1276462T3/da active
- 2001-04-19 CN CN201610529848.2A patent/CN106176665A/zh active Pending
- 2001-04-19 BR BR0110243-5A patent/BR0110243A/pt active Search and Examination
- 2001-04-19 EA EA200201140A patent/EA004980B1/ru not_active IP Right Cessation
- 2001-04-19 ES ES01927200T patent/ES2315282T3/es not_active Expired - Lifetime
- 2001-04-19 CA CA2406277A patent/CA2406277C/en not_active Expired - Lifetime
- 2001-04-19 PT PT01927200T patent/PT1276462E/pt unknown
- 2001-04-19 EP EP01927200A patent/EP1276462B1/de not_active Expired - Lifetime
- 2001-04-19 IL IL15229401A patent/IL152294A0/xx unknown
- 2001-04-19 CN CNA2009101325230A patent/CN101513386A/zh active Pending
- 2001-04-19 AT AT01927200T patent/ATE409023T1/de active
- 2001-04-19 TW TW090109440A patent/TWI290054B/zh not_active IP Right Cessation
- 2001-04-19 CN CNA2008101744723A patent/CN101396335A/zh active Pending
- 2001-04-19 NZ NZ522002A patent/NZ522002A/en not_active IP Right Cessation
- 2001-04-19 JP JP2001577925A patent/JP4705304B2/ja not_active Expired - Lifetime
- 2001-04-19 DE DE60135907T patent/DE60135907D1/de not_active Expired - Lifetime
- 2001-04-26 AR ARP010101963A patent/AR028372A1/es not_active Application Discontinuation
-
2002
- 2002-03-14 US US10/096,877 patent/US20020102307A1/en not_active Abandoned
- 2002-10-15 IL IL152294A patent/IL152294A/en active IP Right Grant
- 2002-10-17 ZA ZA200208415A patent/ZA200208415B/en unknown
-
2003
- 2003-07-18 HK HK03105207.5A patent/HK1053263B/zh not_active IP Right Cessation
-
2005
- 2005-03-15 US US11/081,142 patent/US20050186279A1/en not_active Abandoned
-
2006
- 2006-06-01 AU AU2006202338A patent/AU2006202338B2/en not_active Expired
-
2008
- 2008-12-18 AU AU2008261114A patent/AU2008261114B2/en not_active Expired
- 2008-12-23 CY CY20081101493T patent/CY1108665T1/el unknown
-
2010
- 2010-01-15 US US12/688,132 patent/US8574659B2/en not_active Expired - Fee Related
- 2010-01-19 US US12/689,956 patent/US8574613B2/en not_active Expired - Fee Related
-
2013
- 2013-10-18 US US14/057,847 patent/US9192579B2/en not_active Expired - Fee Related
-
2015
- 2015-10-22 US US14/919,962 patent/US9849085B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60135907D1 (de) | Wirkstoffverabreichungssysteme mit verzögerter freisetzung, verwendung und verfahren zur herstellung derselben | |
DK0861659T3 (da) | Indretninger til administration af lægemidler med forsinket frigivelse | |
YU11100A (sh) | Sistemi koji obezbeđuju podržano oslobađanje leka | |
ATE232089T1 (de) | Implantierbare wiederauffüllbare vorrichtung mit gesteuerter freisetzung zur verabreichung von arzneistoffen unmittelbar an einen inneren teil des körpers | |
WO2000032267A3 (en) | Device for locally delivering a drug in a body cavity | |
BR0000358A (pt) | Liberação controlada por extrusão de dispersões amorfas sólidas de drogas | |
PT973499E (pt) | Sistema de administracao difusor implantavel | |
ATE376851T1 (de) | Gerät zum einbringen eines medikamentes in das respiratorische system | |
EP0863729A4 (de) | Implantierbare vorrichtung zur kontrollierten abgabe von arzneimitteln unmittelbar an einen inneren teil des körpers | |
DE60044082D1 (de) | Gerät und verfahren zur selektiven verabreichung von medikamenten an einen bestimmten ort der wand e | |
WO2003009882A3 (en) | Local concentration management system | |
ATE482001T1 (de) | Medizinprodukt mit arzneimittelzufuhrglied | |
DE69529054D1 (de) | System zur gezielten wirkstoffzufuhr, verfahren zu seiner herstellung und verwendung | |
ATE322296T1 (de) | Aufweitbare vorrichtung aus fluorpolymeren zur verabreichung therapeutischer wirkstoffe | |
DE69705319T2 (de) | Vorrichtung mit mehreren strömungspfaden zur oralen verabreichung von boluseinheiten | |
DK1039861T3 (da) | Medicinsk anordning til intern varmebehandling og tilførsel af medikament | |
TH84091B (th) | ระบบการส่งมอบ | |
TH84091A (th) | ระบบการส่งมอบ | |
UA2702U (uk) | Спосіб лазерного біологічного блокування алкогольної та наркотичної залежності |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |